Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients

Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients

The BK virus (BKV) causes severe hemorrhagic cystitis in hematopoietic stem cell transplant (HSCT) recipients. To eliminate reactivated BKV, symptomatic patients can be treated with a reduction of the immunosuppressive therapy, with the antiviral drug cidofovir, or with virus-specific T cells (VSTs)...

Full description

Bibliographic Details
Main Authors: Michael Koldehoff, Britta Eiz-Vesper, Britta Maecker-Kolhoff, Nina K. Steckel, Ulf Dittmer, Peter A. Horn, Monika Lindemann
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Vaccines
Subjects:
BK virus
hematopoietic stem cell transplantation
treatment with virus-specific T cells
immunosuppression
cidofovir
JC virus
Online Access:https://www.mdpi.com/2076-393X/11/4/845

Internet

https://www.mdpi.com/2076-393X/11/4/845

Similar Items